1. The indications were as follows: 60 times for papillary carcinoma, 45 times for carcinoma of the head of the pancreas, 87 times for severe chronic pancreatitis, twice for adenocystoma of the head of the pancreas, and once each for insuloma and Zollinger-Ellison adenoma.